The International Formulations Business is organized into 3 segments.
The Company believes that there are significant growth opportunities in the relevant emerging markets for its exports business. It has finalised geographies in Africa, Asia and CIS countries where it is confident of significant growth opportunities for the next five years and accordingly formulated business plans with own field operations and setting up a strong distributon network for its products.
The segment primarily includes sales to US, Europe, Canada, New Zealand and Australia. The business in these markets is classified as
The segment involves sale of Company's products pre-qualified by the WHO or the US President's Emergency Plan for AIDS Relief (“PEPFAR”) to global medical institutions or bodies such as United Nations Children's Emergency Fund (“UNICEF”), IDA, GDF, Global Fund, Clinton Foundation, Gates Foundation, Partnership for Supply Chain Management (“PFSCM”) (USA), DFID, UNAID, etc., which fund various global medical programmes
The patient’s identity is held in strict confidence and protected to the fullest extent. Programme staff is not expected to and will not disclose the reporter’s identity in response to a request from the public. Submission of a report does not constitute an admission that medical personnel or manufacturer or the product caused or contributed to the reaction.